Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Viridian Therapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Viridian Therapeutics, Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases with significant unmet medical needs. The company is focused on developing novel therapies for thyroid eye disease and other autoimmune conditions. Viridian leverages innovative antibody technology to create potentially transformative medicines.